Talk to the Institute
Published mark

IONIS PHARMACEUTICALS INC

NASDAQ: IONS. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9
SEC CIK
0000874015
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
Newest evidence
Apr 23, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Brett P. MoniaSince Apr 23, 2026
Chair
Not published
Independent
2 / 22 directors published
Published claims
212 distinct sources
Evidence records
140 pinned
Source conflicts
0None open

Built from 2 distinct sources and 14 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Brett P. Monia executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.

EffectiveEffective Apr 23, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Executive OfficerBrett P. MoniaApr 2026currentSource reportedE3
Executive Vice President, Corporate Development and OperationsBrian BirchlerApr 2026currentSource reportedE4
Executive Vice President, Chief Scientific OfficerC. Frank BennettApr 2026currentSource reportedE5
Executive Vice President, Finance and Chief Financial OfficerElizabeth L. HougenApr 2026currentSource reportedE6
Executive Vice President, ResearchEric E. SwayzeApr 2026currentSource reportedE7
Executive Vice President, Chief Clinical Development and Operations OfficerEugene SchneiderApr 2026currentSource reportedE8
Executive Vice President, Chief Development OfficerHolly KordasiewiczApr 2026currentSource reportedE9
Executive Vice President, Chief Business OfficerJoseph T. BaroldiApr 2026currentSource reportedE10
Executive Vice President, Chief Global Product Strategy OfficerKyle JenneApr 2026currentSource reportedE11
Executive Vice President, Chief Legal Officer, General Counsel and Corporate SecretaryPatrick R. O NeilApr 2026currentSource reportedE12
Executive Vice President, Chief Human Resources OfficerShannon L. DeversApr 2026currentSource reportedE13

Board of directors

Evidence

2 directors published. 2 of 2 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Joan E. HermanIndependent2019CompensationSource reportedE2
Spencer R. BerthelsenIndependent2002CompensationSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
CompensationNot publishedJoan E. Herman, Spencer R. BerthelsenNot described in the published record
Committee RecordCompensation: Chair not stated; Members Joan E. Herman; Spencer R. Berthelsen
Source reportedE14
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_record:19
Committee AppointmentJoan E. Herman: member, Compensation
Source reportedE14
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:20
Committee AppointmentSpencer R. Berthelsen: member, Compensation
Source reportedE14
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:committee_appointment:21

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerBrett P. Monia, Chief Executive Officer, from Apr 23, 2026
Source reportedE3
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:leadership_role:8
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingIONS (NASDAQ)
Source reportedE1
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:security_listing:22
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 17, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameIONIS PHARMACEUTICALS INC
Source reportedE1
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:entity_status:3
Published FactHealthcare
Source reportedE1
company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9:published_fact:5

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
14 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 5 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Ionis Pharmaceuticals DEF 14A 2026-04-23
    sec proxy. Published Apr 23, 2026. Retrieved Jul 12, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    IONS DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    Compensation
    board_seats. board seats. Cited by 3 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026
  • Brett P. Monia executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Brian Birchler executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • C. Frank Bennett executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Elizabeth L. Hougen executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Eric E. Swayze executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Eugene Schneider executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Holly Kordasiewicz executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Joseph T. Baroldi executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Kyle Jenne executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Patrick R. O Neil executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Shannon L. Devers executive of IONIS PHARMACEUTICALS INC, effective 2026-04-23.
  • Joan E. Herman seat on IONIS PHARMACEUTICALS INC, effective 2019-01-01.
  • Joan E. Herman member of Compensation, effective 2019-01-01.
  • Spencer R. Berthelsen seat on IONIS PHARMACEUTICALS INC, effective 2002-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/ionis-pharmaceuticals-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership11
  4. Board2
  5. Committees1
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims4
  15. Coverage gaps17
  16. Linked people13
  17. Subject and corrections6
  18. Evidence14
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:5124c2a9-ab11-4eb4-ab35-3f7ee52af0e9
  • Cite this recordIONIS PHARMACEUTICALS INC
  • Copy canonical URLregistry.alpha.ac/companies/ionis-pharmaceuticals-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    IONIS PHARMACEUTICALS INCCompany
  • Brett P. MoniaPerson
  • Brian BirchlerPerson
  • C. Frank BennettPerson
  • Elizabeth L. HougenPerson
  • Eric E. SwayzePerson
  • Eugene SchneiderPerson
  • Holly KordasiewiczPerson
  • Joseph T. BaroldiPerson
  • Kyle JennePerson
  • Patrick R. O NeilPerson
  • Shannon L. DeversPerson
  • Joan E. HermanPerson
  • Spencer R. BerthelsenPerson
  • Sections
    OverviewIONIS PHARMACEUTICALS INC
  • MonitoringIONIS PHARMACEUTICALS INC
  • LeadershipIONIS PHARMACEUTICALS INC
  • BoardIONIS PHARMACEUTICALS INC
  • CommitteesIONIS PHARMACEUTICALS INC
  • Control and votingIONIS PHARMACEUTICALS INC
  • Authority to actIONIS PHARMACEUTICALS INC
  • FinancialsIONIS PHARMACEUTICALS INC
  • GovernanceIONIS PHARMACEUTICALS INC
  • RiskIONIS PHARMACEUTICALS INC
  • AI oversightIONIS PHARMACEUTICALS INC
  • LegalIONIS PHARMACEUTICALS INC
  • CompensationIONIS PHARMACEUTICALS INC
  • Other published claimsIONIS PHARMACEUTICALS INC
  • Coverage gapsIONIS PHARMACEUTICALS INC
  • Linked peopleIONIS PHARMACEUTICALS INC
  • Subject and correctionsIONIS PHARMACEUTICALS INC
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.